Risk characterization of methyl tertiary butyl ether (MTBE) in tap water

Risk Analysis

Volumn 17, Issue 6, 1997, Pages 727-743

  Stern, Bonnie R ^a   Tardiff, Robert G ^b  

^a Risk Sciences and Management ^*  (United States)

^b The Sapphire Group Inc   (United States)

Author keywords

Drinking water; MTBE; Risk characterization

Indexed keywords

ETHERS; GROUNDWATER POLLUTION; POTABLE WATER; RISK ASSESSMENT; SURFACE WATERS;

METHYL TERTIARY BUTYL ETHER;

HEALTH RISKS;

FUEL; GROUND WATER; SURFACE WATER; TAP WATER; TERT BUTYL METHYL ETHER;

ARTICLE; ATMOSPHERE; BIOASSAY; DILUTION; HALF LIFE TIME; HEALTH HAZARD; HUMAN; INGESTION; INHALATION; LONG TERM EXPOSURE; MUTAGENICITY; NEPHROTOXICITY; NONHUMAN; RISK ASSESSMENT; SKIN; VOLATILIZATION;

ACCIDENTS; AIR POLLUTANTS; ANIMALS; BATHS; CARCINOGENS; DISEASE MODELS, ANIMAL; DRINKING; ENVIRONMENTAL EXPOSURE; FEMALE; FOOD HANDLING; GASOLINE; HUMANS; MALE; MAXIMUM ALLOWABLE CONCENTRATION; METHYL ETHERS; ODORS; PUBLIC HEALTH; RATS; RISK ASSESSMENT; SENSORY THRESHOLDS; SKIN ABSORPTION; SOIL POLLUTANTS; SOLVENTS; TASTE; VOLATILIZATION; WATER; WATER POLLUTANTS, CHEMICAL; WATER SUPPLY;

EID: 0031418187     PISSN: 02724332     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1539-6924.1997.tb01279.x     Document Type: Article

References (47)

1. R. Hartung and S. R. Baker, "MTBE Comparative Risk Assessment: Quantitative Comparisons of Critical Elements Used to Assess Human Health Risks," (unpublished analysis, 1997).
2. U.S. Geological Survey, "Occurrence of the Gasoline Additive MTBE in Shallow Ground Water in Urban and Agricultural Areas," U.S. Geological Survey (March 1995).
3. J. Davidson, R. Rykowski, D. J. Bott, and W. J. Piel, MTBE Releases into the Environment and Its Potential for Occurrence in Water Supplies (ARCO Chemical Co., Newtown Square, PA, 1995), 14 pp.
4. National Research Council, Risk Assessment in the Federal Government: Managing the Process (National Academy Press, Washington, D.C., 1983).
5. R. G. Tardiff and J. V. Rodricks, "Comprehensive Risk Assessment," in R. G. Tardiff and J. V. Rodricks (eds.), Toxic Substances and Human Risk. Principles of Data Interpretation (Plenum Press, New York, 1987), pp. 391-434.
6. S. L. Brown, "Atmospheric and Potable Water Exposures to Methyl Tert-Butyl Ether (MTBE)," Regul. Toxicol. Pharmacol. 25, 256-276 (1997).
7. J. Schaum, K. Hoang, R. Kinerson, J. Moya, and R. Wang, "Estimating Dermal and Inhalation Exposure to Volatile Chemicals in Domestic Water," in R. Wang (ed.), Drinking Water and Health: Integration of Exposure Assessment, Toxicology and Risk Assessment (Marcel Dekker, New York, 1992).
8. N. Fiedler, S. N. Mohr, K. Kellie-McNeil, and H. M. Kipen, "Response of Sensitive Groups to MTBE," Inhal. Toxicol. 6, 539-552.
9. N. J. Balter, "Causality Assessment of the Acute Health Complaints Reported in Association with Oxygenated Fuels," Risk Anal. 17, 705-716 (1997).
10. J. Borak, H. Pastides, M. Van Ert, M. Russi, and J. Herzstein, "Exposure to MTBE and Acute Human Health Effects: A Critical Literature Review," (unpublished analysis, 1997).
11. ARCO, "MTBE: Acute Toxicological Studies," unpublished report, ARCO Chemical Company, Glenolden, Pennsylvania (1980).
12. J. S. Duffy, J. A. Del Pup, and J. J. Kneiss, "Toxicological Evaluation of Methyl Tertiary-Butyl Ether (MTBE): Testing Performed Under TSCA Consent Agreement," J. Soil Contam. 1(1), 29-37 (1992).
13. M. Robinson, R. H. Bruner, and G. R. Olson, "Fourteen- and Ninety-Day Oral Toxicity Studies of Methyl Tertiary-Butyl Ether in Sprague-Dawley Rats," J. Am. Coll. Toxicol. 9, 525-540 (1990).
14. M. G. Bird, H. D. Burleigh-Flayer, J. S. Chun, J. F. Douglas, J. J. Kneiss, and L. S. Andrews, "Oncogenicity Studies of Inhaled Methyl Tertiary-Butyl Ether (MTBE) in CD-1 Mice and F-344 Rats," J. Appl. Toxicol. 17, 45-55 (1997).
15. J. J. Clary, "Methyl Tert-Butyl Ether: Systemic Toxicity," Risk Anal. 17, xxx-xxx (1997).
16. J. H. Mennear and E. E. McConnell, "Carcinogenicity Studies on MTBE: Critical Review and Interpretation," Risk Anal. 17, 673-682 (1997).
17. M. L. Dourson and S. F. Felter, "Route-to-Route Extrapolation of the Toxic Potency of MTBE," Risk Anal. 17, 717-726 (1997).
18. L. Rudeako, K. R. Wilmarth, and T. B. Starr, "MTBE Mode of Action: Implications for Dose-Response," (unpublished analysis, 1997).
19. ITT Research Institute, "28-Day Oral (Gavage) Toxicity Study of Methyl Tert-Butyl Ether (MTBE) in Rats - Final Report," IITRI Project No. L08100, IIT Research Institute, for Amoco Corp., Chicago (1992).
20. D. E. Dodd and W. J. Kintigh, "MTBE: Repeated (13-Week) Vapor Inhalation Study in Rats with Neurotoxicity Evaluation," BRRC Report No. 52-507, Bushy Run Research Center, Export, Pennsylvania (1989).
21. 2μ-Globulin Nephropathy," Annu. Rev Pharmacol. Toxicol 30, 349-367 (1994).
22. R W. Biles, R. E. Schroeder, and C. E. Holdsworth, "Methyl Tertiary Butyl Ether Inhalation in Rats: A Single Generation Reproduction Study," Toxicol. Ind. Health 3, 519-534 (1987).
23. T. L. Neeper-Bradley, "Two-Generation Reproduction Study of Inhaled Methyl Tert-Butyl Ether in CD Sprague-Dawley Rats," Project Report 53-594, Bushy Run Research Center, Export, PA (1991).
24. C. C. Conaway, R. E. Schroeder, and N. K. Snyder, "Teratology Evaluation of Methyl Tertiary Butyl Ether in Rats and Mice," J. Toxicol. Environ. Health 16, 797-807 (1985).
25. R. W. Tyl, "Developmental Toxicity Study of Inhaled Methyl Tertiary Butyl Ether in New Zealand White Rabbits," Project Report 51-268, Bushy Run Research Center, Export, PA (1989).
26. R. W. Tyl and T. L. Neeper-Bradley, "Developmental Toxicity Study of Inhaled Methyl Tertiary Butyl Ether in CD-1 Mice," Project Report 51-266, Bushy Run Research Center, Export, PA (1989).
27. J. A. Swenberg, and D. R. Dietrich, "Immunohistochemical Localization of alpha-2μ-Globulin in Kidneys of Treated and Control Rats of a 13-Week Vapor Inhalation Study Undertaken with Methyl Tertiary-Butyl Ether (MTBE)," Unpublished report to J. Kneiss, SOCMA, CIIT, Research Triangle Park, N.C. (July 1991).
28. R. Garman, "Nephropathy Observed in Male and Female Rats in the Methyl Tertiary Butyl Ether Vapor Inhalation Oncogenicity Study in Fisher 344 Rats," Bushy Run Research Center Report No. 91N00138B, Letter to L. Andrews, ARCO Chemical Co. Murrysville, PA, Consultants in Veterinary Pathology (1993).
29. F. Belpoggi, M. Soffritti, and C. Maltoni, "Methyl Tertiary-Butyl Ether (MTBE) - a Gasoline Additive - Causes Testicular and Lymphohaematopoietic Cancers in Rats," Toxicol. Ind. Health 11, 119-149 (1995).
30. R. Peto, "Epidemiological Reservations About Risk Assessment," in A. D. Woodhead, C. J. Shellabarger, V. Pond, and A. Hollaender (eds.), Assessment of Risk from Low-Level Exposure to Radiation and Chemicals; A Critical Overview (Plenum Press, New York, 1985).
31. R. Doll and R. Peto, "The Causes of Cancer. Quantitative Estimates of Avoidable Risks of Cancer in the United States Today," J. Natl Cancer Inst. 66, 1191-1308 (1981).
32. B. N. Ames, "Endogenous Oxidative DNA Damage, Aging, and Cancer," Free Radic. Res. Commun. 7, 121-128 (1989).
33. R. H. McKee, J. S. Vergnes, J. B. Galvin, J. F. Douglas, J. J. Kneiss, and A. S. Andrews, "Assessment of the in Vivo Mutagenicity Potential of MTBE," J. Appl. Toxicol. (in press).
34. A. C. Gamier, J. G. Harper, F. A. Angelente, G. R. Blackburn, C. A. Schreiner, and C. R. Mackerer, "The Metabolite Formaldehyde is Responsible for the Mutagenicity of Methyl Tertiary Butyl Ether in the Activated Mouse Lymphoma Assay," presented at the Genetic Toxicology Association Annual Meeting, Bushy Run Research Center, Export, Pennsylvania (1993).
35. A. M. Standeven and T. L. Goldsworthy, "Promotion of Preneoplastic Lesions and Induction of CYP2B by Unleaded Gasoline Vapor in Female B6C3F, Mouse Liver," Carcinogenesis 14, 2137-2141 (1993).
36. A. M. Standeven and T. L. Goldsworthy, "Identification of Hepatic Mitogenic and Cytochrome P-450-Inducing Fractions of Unleaded Gasoline in B6C3F1 Mice," J Toxicol. Environ. Health 43, 213-224 (1994).
37. A. M. Standeven, D. G. Blazer, III, and T. L. Goldsworthy, "Investigation of Antiestrogenic Properties of Unleaded Gasoline in Female Mice," Toxicol. Appl. Pharmacol. 127, 233-240 (1994).
38. A. M. Standeven, D. C. Wolf, and T. L. Goldsworthy, "Interactive Effects of Unleaded Gasoline and Estrogen on Liver Tumor Promotion in Female B6C3F1 Mice," Cancer Res. 54, 1198-1204 (1994).
39. A. M. Standeven, D. C. Wolf, and T. L. Goldsworthy, "Promotion of Hepatic Preneoplastic Lesions in Male B6C3F1 Mice by Unleaded Gasoline," Environ. Health Perspect. 103, 696-700 (1995).
40. T. L. Goldsworthy, A. M. Standeven, D. C. Wolf, R. Harden, and G. L. Moser, "Cell Proliferation in Unleaded Gasoline-Promoted Foci in Mouse Liver," presented at Society of Toxicology 34th Annual Meeting, Baltimore, Maryland, March 5-9, Chemical Industry Institute of Toxicology, Research Triangle Park, North Carolina (1995).
41. D. G. Bames and M. Dourson, "Reference Dose (RfD): Description and Use in Health Risk Assessments," Reg Toxicol. Pharmacol. 8, 471-486 (1988).
42. USEPA, "Proposed Guidelines for Carcinogen Risk Assessment," Fed. Reg. 61, 17960-18011 (1996).
43. National Research Council, Drinking Water and Health: Disinfectants and Disinfectant By-Products, Vol. 7 (National Academy Press, Washington, D.C., 1987), p. 130.
44. R. Reitz, A. L. Mendrala, R. A. Corley, J. F. Quast, M. L. Gargas, M. E. Andersen, D. A. Staats, and R. B. Connoly, "Estimating the Risk of Liver Cancer Associated with Human Exposures to Chloroform Using Physiologically Based Pharmacokinetic Modeling," Toxicol. Appl. Pharmacol. 105, 443-459 (1990) [Erratum, Toxicol. Appl. Pharmacol. 110, 536 (1991).]
45. W. E. Pepelko, "Feasibility of Route Extrapolation in Risk Assessment," Br. J. Ind. Med. 44, 649-651 (1987).
46. USEPA, Interim Methods for Development of Inhalation Reference Concentrations, Report No. EPA/600/8-90/066A, U.S. Environmental Protection Agency, Office of Research and Development, Washington, D.C. (1990).
47. USEPA, "Guidelines for Carcinogen Risk Assessment," Fed. Reg. 51 (185), 33992-34003 (1986).